This supports the potential application of MTHFR C677T genotyping in CSVD risk stratification, especially in areas with low dietary folate intake or in populations prone to micronutrient deficiencies, such as the elderly or those with malabsorption syndromes. Here, MTHFR is linked to malabsorption syndrome.